[PCRX] QoQ Quarter Result on 30-Sep-2024 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
06-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -859.64%
YoY- -1,421.29%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 168,573 178,023 167,117 181,244 163,926 169,467 160,341 3.38%
PBT -138,856 36,584 13,640 33,720 16,601 37,854 -26,474 200.96%
Tax -4,610 17,698 4,661 8,850 5,743 12,091 -6,938 -23.79%
NP -143,466 18,886 8,979 24,870 10,858 25,763 -19,536 276.44%
Tax Rate - -48.38% -34.17% -26.25% -34.59% -31.94% - -
Total Cost 312,039 159,137 158,138 156,374 153,068 143,704 179,877 44.22%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -85.11 10.61 5.37 13.72 6.62 15.20 -12.18 264.20%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -3.11 0.41 0.19 0.54 0.23 0.56 -0.43 272.64%
EPS Diluted -3.11 0.39 0.19 0.48 0.23 0.49 -0.43 272.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.